$HTGM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HTG MOLECULAR DIAGNOSTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HTG MOLECULAR DIAGNOSTICS, INC. Get notifications about new insider transactions in HTG MOLECULAR DIAGNOSTICS, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Option Exercise | C | 0.00 | 25,124 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Buy | J | 0.00 | 52 | 0 | 356 | 304 to 356 (+17.11 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Buy | C | 0.00 | 71 | 0 | 304 | 233 to 304 (+30.47 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Buy | C | 0.00 | 233 | 0 | 233 | 0 to 233 |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | C | 0.00 | 126,535 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | X | 0.00 | 126,535 | 0 | 126,535 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | X | 0.00 | 126,535 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | C | 0.00 | 1,895,946 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | C | 0.00 | 574,212 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Buy | C | 0.00 | 1,178 | 0 | 144,366 | 143.2 K to 144.4 K (+0.82 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Buy | C | 0.00 | 21,180 | 0 | 143,188 | 122 K to 143.2 K (+17.36 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Buy | C | 0.00 | 17,321 | 0 | 122,008 | 104.7 K to 122 K (+16.55 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 14.00 | 21,246 | 297,444 | 21,246 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 0.22 | 1,358,988 | 297,482 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 0.00 | 6,091,062 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 0.00 | 26,496,116 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | P | 14.00 | 102,445 | 1,434,230 | 518,595 | 416.2 K to 518.6 K (+24.62 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | J | 0.00 | 68,404 | 0 | 416,150 | 347.7 K to 416.2 K (+19.67 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | J | 14.00 | 44,301 | 620,214 | 347,746 | 303.4 K to 347.7 K (+14.60 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | C | 0.00 | 56,718 | 0 | 303,445 | 246.7 K to 303.4 K (+22.99 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | C | 0.00 | 246,727 | 0 | 246,727 | 0 to 246.7 K |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 43,538 | 0 | 43,538 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 2,784,593 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 110,755 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 15,227,653 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 36,546,366 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 110,755 | 0 | 1,049,243 | 938.5 K to 1 M (+11.80 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | J | 0.00 | 91,271 | 0 | 938,488 | 847.2 K to 938.5 K (+10.77 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 141,797 | 0 | 847,217 | 705.4 K to 847.2 K (+20.10 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 340,314 | 0 | 705,420 | 365.1 K to 705.4 K (+93.21 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 14.00 | 365,106 | 5,111,484 | 365,106 | 0 to 365.1 K |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | X | 0.00 | 49,786 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 110,755 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 156,123 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 598,415 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | P | 14.00 | 365,106 | 5,111,484 | 1,280,185 | 915.1 K to 1.3 M (+39.90 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | X | 0.00 | 49,786 | 0 | 915,079 | 865.3 K to 915.1 K (+5.75 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 110,755 | 0 | 865,293 | 754.5 K to 865.3 K (+14.68 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 754,538 | 0 | 754,538 | 0 to 754.5 K |